Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking. Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R. Sci Rep. 2022 Aug 30;12(1):14754.

30 Aug 2022
0

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Sci Rep. 2022 Aug 30;12(1):14754.

Tags

Share this

Related Posts

Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study. Saruengkhanphasit R, Butkinaree C, Ornnork N, Lirdprapamongkol K, Niwetmarin W, Svasti J, Ruchirawat S, Eurtivong C*. Bioorg Chem. 2021 May;110:104795.
Health risk evaluation in a population exposed to chemical releases from a petrochemical complex in Thailand. Kampeerawipakorn, O., Navasumrit, P., Settachan, D., Promvijit, J., Hunsonti, P., Parnlob, V., Ruchirawat, M. (2017). Environmental Research, 152.

Recent Posts